(Q34677578)

3 August 2017

1 reference

title

Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics (English)

1 reference

3 August 2017

0 references

0 references

John G Csernansky

1

1 reference

3 August 2017

Emily K Schuchart

series ordinal

2

1 reference

3 August 2017

publication date

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

16

1 reference

3 August 2017

issue

7

1 reference

3 August 2017

page(s)

473-484

1 reference

Predictability of rehospitalization for schizophrenia

3 August 2017

cites work

1 reference

12 December 2020

Review of atypical antipsychotics and weight gain.

1 reference

12 December 2020

Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol

1 reference

12 December 2020

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

12 December 2020

Tolerability of atypical antipsychotics

1 reference

12 December 2020

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

12 December 2020

Psychiatric and social reasons for frequent rehospitalization

1 reference

12 December 2020

Maintenance Medication for Schizophrenia: Strategies for Dose Reduction

1 reference

12 December 2020

Clozapine: diabetes mellitus, weight gain, and lipid abnormalities.

1 reference

12 December 2020

Why do schizophrenic patients refuse to take their drugs?

1 reference

12 December 2020

Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia

1 reference

12 December 2020

Rehospitalization in chronic schizophrenia

1 reference

12 December 2020

Risperidone-associated new-onset diabetes

1 reference

12 December 2020

Relapse and Rehospitalization During Maintenance Treatment of Schizophrenia

1 reference

12 December 2020

Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol

1 reference

12 December 2020

Measuring neuropsychological change in schizophrenia with novel antipsychotic medications

1 reference

12 December 2020

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

12 December 2020

Assessing clinical predictions of early rehospitalization in schizophrenia

1 reference

12 December 2020

Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia

1 reference

12 December 2020

Neuroleptic-induced akathisia: a review

1 reference

12 December 2020

Correlations between akathisia and residual psychopathology: a by-product of neuroleptic-induced dysphoria

1 reference

12 December 2020

A two-year clinical and economic follow-up of patients on clozapine

1 reference

12 December 2020

Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.

1 reference

12 December 2020

Risperidone in the treatment of schizophrenia

1 reference

12 December 2020

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

12 December 2020

Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia

1 reference

12 December 2020

Gender differences in schizophrenia: rehospitalization and community survival.

1 reference

12 December 2020

Quality of life and clinical predictors of rehospitalization of persons with severe mental illness

1 reference

12 December 2020

Patients' opinions concerning side effects of depot neuroleptics.

1 reference

12 December 2020

Drug refusal in schizophrenia and the wish to be crazy

1 reference

12 December 2020

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

1 reference

12 December 2020

Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point

1 reference

12 December 2020

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

12 December 2020

Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment

1 reference

12 December 2020

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia

1 reference

12 December 2020

Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome

1 reference

12 December 2020

Cost-effectiveness of clozapine treatment in therapy-refractory schizophrenia.

1 reference

12 December 2020

Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder.

1 reference

12 December 2020

Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia

1 reference

12 December 2020

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients

1 reference

12 December 2020

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

1 reference

12 December 2020

Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample.

1 reference

12 December 2020

A controlled dose comparison of haloperidol in newly admitted schizophrenic patients

1 reference

12 December 2020

Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients

1 reference

12 December 2020

Appraisal of the tranquilizers and their influence on other somatic treatments in psychiatry

1 reference

12 December 2020

Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: comparison with risperidone

1 reference

12 December 2020

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

12 December 2020

Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance

1 reference

12 December 2020

Suicide attempts associated with akathisia

1 reference

12 December 2020

Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi.

1 reference

12 December 2020

Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.

1 reference

12 December 2020

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

12 December 2020

Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double- blind, placebo-controlled, multicenter studies

1 reference

12 December 2020

Ziprasidone: comprehensive overview and clinical use of a novel antipsychotic

1 reference

12 December 2020

Predicting medication noncompliance after hospital discharge among patients with schizophrenia

1 reference

12 December 2020

Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates

1 reference

12 December 2020

Risk of rehospitalization of psychotic patients. A 6-year follow-up investigation using the survival approach

1 reference

12 December 2020

Novel antipsychotics and new onset diabetes

1 reference

12 December 2020

Symptoms of schizophrenia. Methods, meanings, and mechanisms.

1 reference

12 December 2020

Cost of relapse in schizophrenia

1 reference

12 December 2020

Schizophrenia costs and treatment cost-effectiveness.

1 reference

12 December 2020

A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia

1 reference

12 December 2020

Effectiveness of clozapine and olanzapine: a comparison in severe, psychotically ill patients

1 reference

12 December 2020

Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics

1 reference

12 December 2020

Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders

1 reference

12 December 2020

Neuroleptics. Violence as a manifestation of akathisia

1 reference

12 December 2020

Partial versus full hospitalization for adults in psychiatric distress: a systematic review of the published literature (1957-1997).

1 reference

12 December 2020

Maintenance therapy and the natural course of schizophrenia.

1 reference

12 December 2020

Adherence to antipsychotic medications.

1 reference

12 December 2020

Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Results of a two-year controlled study.

1 reference

12 December 2020

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

1 reference

12 December 2020

10.2165/00023210-200216070-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1027093879

0 references

1 reference